Houlihan Lokey is pleased to announce that Kingswood Capital Management (Kingswood) has received a strategic minority GP stake investment from Bonaccord Capital Partners (Bonaccord).
Houlihan Lokey’s GP Advisory team served as Kingswood’s sole sell-side advisor. Since mid-March, the GP Advisory team has served as our clients' sole advisor on six GP stake transactions and one GP control M&A transaction.
Kingswood is a Los Angeles-based private equity firm that partners with leading companies that stand to benefit from its capital and extensive operating resources. Kingswood embraces complexity and believes it is well positioned to support businesses at inflection points in their development to enhance value.
Kingswood pursues a differentiated investment strategy that has delivered results even amid a broader slowdown in deal flow and in a turbulent market cycle. The firm has also seen significant growth, closing Fund III in the summer of 2024 after just 90 days with total capital commitments of $1.5 billion, surpassing its $1.0 billion target.
Bonaccord is a private equity firm focused on providing growth capital and strategic support to middle-market private markets sponsors. Bonaccord’s investment will enable Kingswood to expand its capital base and reinvest in the firm, ultimately positioning Kingswood to build on its substantial success over the past several years. There will be no changes to management, investment strategy, or firm operations.
Houlihan Lokey served as the sole sellside financial advisor to Kingswood and assisted in marketing, structuring, and negotiating this transaction. This deal represents an additional successful engagement for Houlihan Lokey’s market-leading GP Advisory platform, having served as our clients’ sole advisor across seven transactions over the past eight months.
If you would like more information about Houlihan Lokey or have questions regarding the firm’s role in this transaction, please contact one of the deal team members listed below.
| 
